{
  "id": "a0fd77d08506e88a",
  "title": "STAT+: Moderna\u2019s president weighs in on FDA\u2019s decision not to review its flu vaccine",
  "description": "In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well as the impact on the company and others in&#8230;",
  "content": "In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well as the impact on the company and others in&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/12/moderna-stephen-hoge-interview-flu-vaccine/?utm_campaign=rss",
  "published_at": "2026-02-12T23:23:20+00:00",
  "fetched_at": "2026-02-13T00:31:20.432552+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Moderna\u2019s president weighs in on FDA\u2019s decision not to review its flu vaccine",
    "description": "In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well as the impact on the company and others in&#8230;",
    "url": "https://www.statnews.com/2026/02/12/moderna-stephen-hoge-interview-flu-vaccine/?utm_campaign=rss",
    "published": "2026-02-12T23:23:20+00:00",
    "source": "STAT"
  }
}